The PHTI report analyzes the actual adoption of AI in U.S. healthcare systems: few tangible clinical benefits, limited transparency, and a high risk of bias. Italy can avoid the same mistakes by focusing on validation, interoperability, and industrial accountability.
WHO relaunches global health with the 2025–2028 strategy, focusing on equity, resilience, and collaboration. Climate, access to medicines, innovation, and stronger health systems are at the heart of an agenda that also calls the pharmaceutical industry to action.
BSI, full-scope Notified Body for all three types of devices pursuant to MDR and IVDR, is able to offer verification services for compliance with European directives about the production of medical devices
Deimos Group is a leading distributor of raw materials, ingredients and speciality chemicals for industries operating in Pharmaceutical, Pharma Intermediates, Nutraceutical, Food, Cosmetic, Animal Nutrition, Agricultural and Industrial sectors
In the March multimedia magazine, we explore the impact of artificial intelligence and cybersecurity regulations in the pharmaceutical industry.
As artificial intelligence reshapes drug development,...
